Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camostat and Artemisia annua in high-risk COVID-19 outpatients
NCT04530617Phase 2Terminated
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Oct 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of camostat mesilate, artemisia annua in coronavirus disease 2019 (COVID-19), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Started Oct 2020; status: terminated.
02
Drugs
camostat mesilateartemisia annua
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04530617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530617.